ConductScience.org, home

Paper3759657

K-252a, a potent inhibitor of protein kinase C from microbial origin.

Kase H and 2 others. J Antibiot (Tokyo), 1986. Cited by 299 papers, by iCite.

Cite this record

ConductScience Library. K-252a, a potent inhibitor of protein kinase C from microbial origin. Papers, record 3759657. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3759657

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
K-252a, a potent inhibitor of protein kinase C from microbial origin.
PubMed
Journal
J Antibiot (Tokyo)
PubMed
Year
1986
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
299
iCite
Relative citation ratio, by iCite
8.17
iCite
Revised in PubMed
2019-07-23
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kase HH
2Iwahashi KK
3Matsuda YY

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CarbazolesMajor topic
Protein Kinase CMajor topic
Actinomycetales
Animals
Bacteria
Calmodulin
Fermentation
Indole Alkaloids
Mice
Phosphodiesterase Inhibitors

Source PubMed

Download CSV of topics

Cited by52

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 299 citations.

PMIDTitleJournalYearIn PapersSource
42676594Differential effects of cannabidiol on inhibitory avoidance memory reconsolidation and consolidation are associated with distinct hippocampal proBDNF and BDNF signaling profiles.Front Neurosci2026https://conductscience.org/library/papers/42676594PubMed
42566421Delayed growth of SK-ES-1 Ewing sarcoma tumor xenografts is associated with reduced Trk and IGF1R pathway markers.Oncotarget2026https://conductscience.org/library/papers/42566421PubMed
41096950Staurosporine as an Antifungal Agent.Int J Mol Sci2025https://conductscience.org/library/papers/41096950PubMed
40978808CAMKV Kinase Signaling Is a Novel Therapeutic Avenue with Prognostic Relevance in Neuroblastoma.bioRxiv2024https://conductscience.org/library/papers/40978808PubMed
38399426The Antitubercular Activities of Natural Products with Fused-Nitrogen-Containing Heterocycles.Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/38399426PubMed
38099919Chemistry and biology of specialized metabolites produced by Actinomadura.Nat Prod Rep2024https://conductscience.org/library/papers/38099919PubMed
35923716FLT3 inhibitors for acute myeloid leukemia: successes, defeats, and emerging paradigms.RSC Med Chem2022https://conductscience.org/library/papers/35923716PubMed
35736177Genus Nocardiopsis: A Prolific Producer of Natural Products.Mar Drugs2022https://conductscience.org/library/papers/35736177PubMed
34774343A review of FLT3 inhibitors in acute myeloid leukemia.Blood Rev2022https://conductscience.org/library/papers/34774343PubMed
31118539Synthetic Applications and Methodological Developments of Donor-Acceptor Cyclopropanes and Related Compounds.Isr J Chem2016https://conductscience.org/library/papers/31118539PubMed
31026161Fixing the Unfixable: The Art of Optimizing Natural Products for Human Medicine.J Med Chem2019https://conductscience.org/library/papers/31026161PubMed
30134565New Cytotoxic Cyclic Peptide from the Marine Sponge-Associated Nocardiopsis sp. UR67.Mar Drugs2018https://conductscience.org/library/papers/30134565PubMed
30026697c-Jun N-Terminal Kinases (JNKs) in Myocardial and Cerebral Ischemia/Reperfusion Injury.Front Pharmacol2018https://conductscience.org/library/papers/30026697PubMed
29934602Staurosporine: new lease of life for parent compound of today's novel and highly successful anti-cancer drugs.J Antibiot (Tokyo)2018https://conductscience.org/library/papers/29934602PubMed
29781959Involvement of the VGF-derived peptide TLQP-62 in nerve injury-induced hypersensitivity and spinal neuroplasticity.Pain2018https://conductscience.org/library/papers/29781959PubMed
29710816Natural Product Potential of the Genus Nocardiopsis.Mar Drugs2018https://conductscience.org/library/papers/29710816PubMed
29690896Marine-derived protein kinase inhibitors for neuroinflammatory diseases.Biomed Eng Online2018https://conductscience.org/library/papers/29690896PubMed
29661832Kinase activity in the olfactory bulb is required for odor memory consolidation.Learn Mem2018https://conductscience.org/library/papers/29661832PubMed
28660044The total synthesis of K-252c (staurosporinone) via a sequential C-H functionalisation strategy.Chem Sci2016https://conductscience.org/library/papers/28660044PubMed
28305726Metamorphosis inHydractinia: Studies with activators and inhibitors aiming at protein kinase C and potassium channels.Rouxs Arch Dev Biol1990https://conductscience.org/library/papers/28305726PubMed

See all 52 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3759657

GET https://conductscience.org/api/papers/v1/3759657/cited_by?page=2